Recent Successes 2005 Archive
October 17, 2005
Fitch Even is pleased to report that client, Cytomedix, Inc., has settled its patent infringement lawsuit with Perfusion Partners and Associates Inc. (PPAI), as well as a separate suit against SafeBlood Technologies, Inc. Both suits included claims for infringement of Cytomedix's "Knighton' patent related to the use of autologous platelet releasate gels for the healing of tissue.
The lawsuits were each resolved through the entry of license agreements by which Cytomedix will receive royalties for use of the patented technology in platelet gel disposable kits and treating services sold by PPAI and SafeBlood. These latest agreements mark the successful completion of a series of patent infringement suits pursued by Fitch Even in several district courts to enforce Cytomedix's patent rights throughout the platelet gel therapy industry.
Fitch Even also recently completed negotiations on another transaction by which COBE Cardiovascular, Inc., a member of Sorin Group, purchased a worldwide license to the Knighton patent for various applications of the Cytomedix patented autologous platelet releasate healing technology. In a joint press release, both parties to the transaction agreed that this latest deal should help further expand the global marketplace for platelet-gel therapies for wound healing and a variety of other clinical applications.
Fitch Even attorney Tim Maloney served as Cytomedix's lead negotiator for these three deals.
